111° West Capital

Background

Founded in 2021, 111° West Capital is a venture capital firm specializing in investments within the healthcare technology sector. The firm focuses on partnering with enterprise software and fintech companies that are transforming healthcare delivery. Led by medical physicians with extensive experience as founders, investors, and executives, 111° West Capital aims to drive significant growth and create substantial value for its portfolio companies.

Key Strategic Focus

111° West Capital's strategic focus centers on multi-stage investments in commercial-stage companies within the healthcare technology domain. The firm emphasizes a hands-on approach, leveraging its investment team and operator network to achieve breakthrough growth leading to successful exits. By concentrating on enterprise software and fintech solutions that address critical healthcare challenges, 111° West Capital positions itself as a catalyst for innovation and efficiency in the healthcare industry.

Financials and Funding

Since its inception, 111° West Capital has actively invested in several healthcare technology companies. Notable investments include:

Arine: Participated in a $29 million Series B funding round in August 2022.

Codoxo: Contributed to a $5 million funding round in February 2022.

These investments reflect the firm's commitment to supporting innovative solutions in healthcare technology.

Pipeline Development

As an investment firm, 111° West Capital's pipeline development is reflected through its portfolio companies' progress. For instance, Arine, a company specializing in medication management platforms, has advanced through multiple funding rounds, indicating significant development and market traction.

Technological Platform and Innovation

111° West Capital distinguishes itself through its focus on enterprise software and fintech solutions that address healthcare challenges. The firm's investment strategy emphasizes:

Proprietary Technologies: Investing in companies with unique technological solutions that enhance healthcare delivery.

Scientific Methodologies: Supporting ventures that employ data-driven approaches and advanced analytics to improve patient outcomes and operational efficiency.

By backing companies that leverage cutting-edge technologies, 111° West Capital contributes to the advancement of healthcare innovation.

Leadership Team

The leadership team at 111° West Capital comprises experienced professionals with backgrounds in medicine, investment, and entrepreneurship:

Andrew Brooks, M.D.: Co-Founder and Managing Partner.

Michael Matly, M.D.: Co-Founder and Managing Partner.

Daniel Tully: Principal.

Their combined expertise enables the firm to provide strategic guidance and support to portfolio companies.

Leadership Changes

As of the latest available information, there have been no significant changes or appointments within the leadership team of 111° West Capital.

Competitor Profile

Market Insights and Dynamics

The healthcare technology investment sector is experiencing substantial growth, driven by increasing demand for innovative solutions that enhance patient care and operational efficiency. The market is characterized by rapid technological advancements and a competitive landscape where venture capital firms play a pivotal role in nurturing emerging companies.

Competitor Analysis

Key competitors in the healthcare-focused venture capital space include:

Hyde Park Venture Partners: With a revenue of approximately $1.1 million and six employees, this firm invests in high-growth technology companies.

King River Capital: Employing 11 individuals and generating around $1.2 million in revenue, King River Capital focuses on technology investments.

These firms, among others, contribute to a dynamic and competitive investment environment in the healthcare technology sector.

Strategic Collaborations and Partnerships

111° West Capital collaborates with various co-investors to strengthen its market position and enhance innovation capacity. Notable co-investors include:

Katalyst.Ventures: Collaborated in funding rounds for companies like Arine.

New Leaf Venture Partners: Participated alongside 111° West Capital in healthcare technology investments.

These partnerships enable the firm to leverage collective expertise and resources, thereby amplifying the impact of their investments.

Operational Insights

In the competitive landscape of healthcare technology investment, 111° West Capital differentiates itself through:

Medical Expertise: Led by medical professionals, the firm offers unique insights into healthcare challenges and solutions.

Hands-On Approach: Active involvement in guiding portfolio companies towards growth and successful exits.

Focus on Innovation: Emphasis on investing in companies with transformative technologies that address critical healthcare needs.

These operational strategies position 111° West Capital as a valuable partner for healthcare technology companies seeking growth and market impact.

Strategic Opportunities and Future Directions

Looking ahead, 111° West Capital aims to:

Expand Investment Portfolio: Continue identifying and investing in promising healthcare technology companies.

Enhance Collaborative Networks: Strengthen partnerships with co-investors and industry stakeholders.

Drive Healthcare Innovation: Support the development and scaling of technologies that improve healthcare delivery and patient outcomes.

By leveraging its current strengths and strategic focus, 111° West Capital is well-positioned to capitalize on emerging opportunities in the healthcare technology sector.